Funded Grants

The Canadian Platform for Trials in Non-Invasive Brain Stimulation (CanStim) is national research platform whose goal is to create a network of sites across Canada for clinical trials that can develop and test the use of different types of non-invasive brain stimulation as an additional therapy option for people with stroke to help them better recover their ability to move their hands and arms after a stroke.

One in four strokes are caused by a condition called cerebral small vessel disease (CSVD). There are no approved treatments for CSVD.

Diabetes distress, the negative emotional feelings resulting from living with diabetes and the burden of selfmanagement, is a very common challenge for people living with type 1 diabetes affecting approximately 40%.

Self-compassion is a practice that involves acting the same way towards yourself as you would with friends and loved ones, and that you are kind and understanding towards yourself.

Age is the most important risk factor for Parkinson’s Disease (PD), followed by sex, with a higher risk in males.

Among the earliest signs of preclinical Alzheimer’s disease (AD) are navigation impairments and the presence of abnormal Tau (aTau) proteins in the entorhinal cortex (EC), a brain region that represents space and movement.

Ischemic stroke occurs when a person suffers a sudden blockage of an artery in their brain.

Carotid disease accounts for 10% of ischemic strokes and has high rate of recurrence of up to 30%-50%(1, 2).

Atrial fibrillation (AF) is the most common heart rhythm disorder.

Acute ischemic stroke represents the vast majority of strokes.